Ocular Therapeutix Aktie
WKN DE: A1180P / ISIN: US67576A1007
|
15.04.2024 13:59:32
|
Ocular Therapeutix CEO Mattessich To Step Down, Dugel To Succeed
(RTTNews) - Ocular Therapeutix, Inc. (OCUL) announced on Monday that President and CEO Antony Mattessich will be stepping down.
Mattessich is being succeeded by Pravin Dugel, executive chairman, who will assume the roles of president and CEO, effective immediately.
In addition to these new responsibilities, Dugel will maintain his positions as a director and executive chairman of the company.
Dugel has previously served in leadership roles such as President of Iveric Bio, Inc.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ocular Therapeutix Incmehr Nachrichten
|
04.08.25 |
Ausblick: Ocular Therapeutix mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
|
04.05.25 |
Ausblick: Ocular Therapeutix legt Quartalsergebnis vor (finanzen.net) |
Analysen zu Ocular Therapeutix Incmehr Analysen
Aktien in diesem Artikel
| Ocular Therapeutix Inc | 9,75 | 0,37% |
|